NFKB1 and optic neuritis: VPA treatment of optic neuritis, reduced optic nerve mRNA expression of TNF-α and Il-1β, inhibited upregulation of phosphorylated NF-κB p65 and downregulation of IκB suggesting a suppression of the NF-κB signaling pathway (Liu et al., 2017).